Paras Healthcare Limited (PARASHLTH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Paras Healthcare Limited on NSE and BSE, with an AI summary of each filing.
Schedule of Earnings Conference Call on the unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and half year ended September 30, 2026
Intimation · 06 Nov 2026, 5:30 pm
Paras Healthcare Schedules Q2 and H1FY27 Earnings Conference Call Paras Healthcare Limited has scheduled its Q2 and H1FY27 earnings conference call for investors and analysts on 6th Nov'26 at 05:30 PM IST. Organised by JM Financial Institutional Securities, the call will discuss the financial results for the quarter and half-year ended 30th Sep'26. Key management participants include Managing Director Dr. Dharminder Kumar Nagar and Group CFO Dilip Bidani. Universal access dial-in numbers are +91 22 6280 1366 and +91 22 7115 8267.
Paras Healthcare Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Paras Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited standalone and consolidated ....
Intimation · 05 Nov 2026, 5:30 am
Paras Healthcare Schedules Board Meeting to Approve Q2 and H1'27 Results Paras Healthcare Limited has scheduled a meeting of its Board of Directors on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed for designated persons and their immediate relatives from 28th Oct'26 and will remain shut until 48 hours following the declaration of the financial results.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations 2011 as amended ("SEBI SAST Regulations")
Others (Uncategorized) · 30 Oct 2026, 10:42 pm
360 ONE Discloses 7.28% Stake in Paras Healthcare Following IPO Listing Paras Healthcare Limited received a SEBI SAST Regulation 29(1) disclosure from 360 ONE entities (including various series of 360 ONE Special Opportunities Fund, Private Equity Fund, and Equity Opportunity Fund). Following the conversion of unlisted shares into listed equity upon the company's IPO listing on 28th Oct'26, 360 ONE along with PACs holds 78,81,992 equity shares, representing 7.28% of the company's total voting capital and diluted share capital of 10,82,01,194 and 10,85,00,790 shares, respectively.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 360 ONE Special Opportunities Fund Series 9 & Others
Acquisition/ Disposal of Shares · 30 Oct 2026, 8:37 pm
360 ONE Funds Disclose 7.28% Stake in Paras Healthcare Post-IPO Listing 360 ONE Asset Management entities, including Special Opportunities, Private Equity, and Equity Opportunity funds, filed a SEBI SAST Regulation 29(1) disclosure for Paras Healthcare Ltd following its IPO listing on 28th Oct'26. The entities hold an aggregate of 78,81,992 equity shares, representing 7.28% of the company's total voting capital (10,82,01,194 shares) and 7.28% on a diluted basis (10,85,00,790 shares). The transaction reflects the conversion of existing unlisted pre-IPO holdings into listed shares, with no new shares acquired during the event.